Search for: "PFIZER PHARMACEUTICALS" Results 141 - 160 of 1,413
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Nov 2009, 6:01 am
Across the U.S., pharmaceutical companies have been pleading guilty to criminal charges or paying penalties in civil cases when the U.S. [read post]
16 Dec 2009, 9:37 am by Peter Rost
darkness of the pharmaceutical industry titled subtitle is "the identity of the world's largest pharmaceutical company Pfizer," the term. ??????????????????????????????? [read post]
31 Jul 2011, 9:44 pm by Patent Docs
Hetero Drugs Ltd. et al. 1:11-cv-05135; filed July 26, 2011 in the Southern District of New York • Plaintiffs: Pfizer Inc.; Pfizer Ltd.; Pfizer Ireland Pharmaceuticals • Defendants: Hetero Drugs Ltd.; Hetero USA Inc.; Invagen Pharmaceuticals Inc.; Hetero Labs Ltd., Unit V Infringement of U.S. [read post]
23 Nov 2015, 12:00 am
U.S. pharmaceutical giant Pfizer announced Nov. 23 a record-breaking $160 billion merger with Irish firm Allergan, the biggest merger to-date involving the controversial strategy of tax inversion. [read post]
2 Sep 2009, 4:08 pm
News release: " American pharmaceutical giant Pfizer Inc. and its subsidiary Pharmacia & Upjohn Company Inc. [read post]
2 Sep 2009, 8:24 pm
A landmark $2.3 billion health-care fraud settlement involving Pfizer Inc., has put the pharmaceutical industry on notice that promoting drugs for unauthorized uses won't be tolerated by the Obama administration, government officials and legal experts said. [read post]
12 Feb 2014, 7:36 am by Damien Geradin
Abstract: The January 2012 decision of the Italian Competition Authority (“ICA”) to fine Pfizer and Pharmacia €10.6 million is an illustration of the more aggressive trend taken by competition authorities in the pharmaceutical sector. [read post]
26 Jun 2012, 8:15 am
Food and Drug Administration has approved the use of Pfizer, Inc.'s nerve pain drug Lyrica for use on some types of patients suffering spinal cord injuries. [read post]
26 Jun 2012, 8:15 am
Food and Drug Administration has approved the use of Pfizer, Inc.'s nerve pain drug Lyrica for use on some types of patients suffering spinal cord injuries. [read post]
10 Sep 2009, 8:48 am by Jeff Lowe
Pharmaceutical company Pfizer Inc. will pay $2.3 billion to the federal and state governments over allegations that it illegally marketed several drugs for off-label uses, the New York Times reported Sept. 2. [read post]
9 Oct 2011, 9:37 pm by Patent Docs
Pfizer Inc. et al. v. [read post]
8 Feb 2012, 10:55 am
Pfizer, Inc., an American multinational pharmaceutical conglomerate, and the maker of many popular drugs such as Lipitor and Viagra, had better hope that the latter of those inventions doesn’t exacerbate the already enormous concern caused by their latest product recall. [read post]
19 Feb 2016, 1:30 pm by Tom Lamb
Some patients who developed melanoma after using Viagra have filed a drug injury lawsuits against the pharmaceutical company Pfizer seeking legal compensation. [read post]
30 Dec 2017, 7:44 am
On November 23rd, 2015, pharmaceutical giant, Pfizer, officially announced that it had reached an agreement with its competitor, Allergan, to merge the two companies in a deal that would have created the largest pharmaceutical company in the world. [read post]
27 Sep 2022, 12:56 pm by Tom Smith
The program includes multiple internships, a fully funded masters degree, and several years of guaranteed employment with the pharmaceutical giant. [read post]
11 Jan 2015, 9:59 pm by Patent Docs
Mylan Inc. et al. 1:15-cv-00026; filed January 8, 2015 in the District Court of Delaware • Plaintiffs: Pfizer Inc.; Wyeth LLC; Pfizer Pharmaceuticals LLC; PF Prism C.V.; Pfizer Manufacturing Holdings LLC • Defendants: Mylan Inc.; Agila Specialties Private Ltd.; Mylan Pharmaceuticals Inc. [read post]
17 Mar 2024, 2:00 am by Katharine Van Tassel
Miroslava Marinova (University of East London), Rethinking the legal test for excessive pricing: Insights from the Landmark UK CMA v Pfizer/Flynn Case and Its Legal Implications (2023): The legal treatment of excessive pricing in the pharmaceutical sector has been a... [read post]